Tumour markers in serum, bronchoalveolar lavage and biopsy cytosol in lung carcinoma: What environment lends the optimum diagnostic yield?

Clinica Chimica Acta

Volumn 305, Issue 1-2, 2001, Pages 27-34

  Pina, Teresa Casas ^a   Zapata, Isabel Tovar ^a   Hernández, Francisco Cañizares ^a   López, Juan Bermejo ^a   Paricio, Pascual Parrilla ^a   Hernández, Pedro Martínez ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

BAL; CA 125; CEA; Lung; NSE; SCC; TPS

Indexed keywords

CA 125 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; NEURON SPECIFIC ENOLASE; SQUAMOUS CELL CARCINOMA ANTIGEN; TISSUE POLYPEPTIDE ANTIGEN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANCER DIAGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOL; DIAGNOSTIC ACCURACY; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; LUNG BIOPSY; LUNG CARCINOMA; LUNG LAVAGE; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC;

ADULT; AGED; BIOPSY; BRONCHOALVEOLAR LAVAGE FLUID; CYTOSOL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0035106641     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(00)00410-1     Document Type: Article

References (36)

1. Carcinoma of the lung: Warts and all
2. Biology and molecular genetics of lung cancer
3. Introduction
4. DNA aneuploidy, S-phase fraction and nuclear p53 positivity in non-small cell lung cancer
5. Tumor markers in lung cancer: Does the method of obtaining the cut-off point and reference population influence diagnostic yield?
6. Clinical usefulness of serum assays of neuron-specific enolase carcinoembryonic antigen and CA-50 antigen in the diagnosis of lung cancer
7. The tissue polypeptide antigen serum test in the pre-operative evaluation of non-small cell lung cancer
8. Measurement of the serum marker neuron-specific enolase in patients with benign pulmonary diseases
9. Serum markers CASA CEA. CYFRA21-1 MSA NSE TPA and TPS in lung cancer
10. Clinical applications of serum markers for lung cancer
11. Evaluation of the serum markers CEA NSE TPS and CYFRA 21.1 in lung cancer
12. Serum tumor markers in non-small cell lung cancer
13. Clinical evaluation of serum tissue polypeptide-specific antigen (TPS) in non-small cell lung cancer
14. Squamous cell carcinoma antigen (SCC Ag) in the diagnosis and prognosis of lung cancer
15. Usefulness of carcinoembryonic antigen determination in bronchoalveolar lavage fluid
16. High neuron specific enolase levels in bronchoalveolar fluid of patients with lung carcinoma
17. The clinical value of neuron-specific enolase as a tumor marker in bronchoalveolar lavage
18. Bronchoalveolar lavage fluid level or cea in the diagnosis of peripheral lung cancers
19. Cytokeratin tumor marker levels in bronchial washing in the diagnosis of lung cancer
20. El componente citológico y bioquímico en 203 lavados broncoalveolares. Valores de referencia
21. Relación entre niveles séricos y citosólicos de los marcadores tumorales CEA CA 125 y SCC en pacientes con carcinoma broncogénico no microcítico
22. Occurrence of neuron specific enolase in tumour tissue and serum in small cell lung cancer
23. Quantitative analysis of carcinoembryonic antigen squamous cell carcinoma antigen CA 125 and CA 50 cytosolic content in non-small cell lung cancer
24. Effect of molybdate on activation and stabilizaton of steroid receptors
25. Evaluation of albumin as a reference marker of dilution in bronchoalveolar lavage fluid from asthmatic and control subjects
26. Las curvas ROC en la evaluación de las pruebas diagnósticas
27. CEA, NSE and SCC Ag in bronchial lavage in patients with lung cancer
28. Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer
29. The usefulness of carcinoembryonic antigen testing in the overall management of patients with non-small-cell lung cancer
30. Multiple markers for lung cancer diagnosis: Validation of models for advanced lung cancer
31. Multiple markers for lung cancer diagnosis: Validation of models for localized lung cancer
32. Serum tumour markers in lung cancer: History biology and clinical applications
33. Clinical evaluation of seven tumour markers in lung cancer diagnosis: Can any combination improve the results?
34. Utilidad clínica de la determinación del antígeno carcinoembrionario (CEA) en suero, lavado broncoalveolar y material histológico en los carcinomas broncopulmonares
35. Airway carcinoembryonic antigen concentrations in patients with central lung cancer or chronic bronchitis